Insilico Medicine Expands Middle East Presence with UAE AI Drug Discovery Partnership

Insilico Medicine Expands Middle East Presence with UAE AI Drug Discovery Partnership

  • March 6, 2026

Hong Kong listed biotechnology company Insilico Medicine has expanded its global footprint through a new partnership in the United Arab Emirates aimed at accelerating artificial intelligence driven drug discovery. The agreement was signed with the UAE’s national drug regulator during a major healthcare

Why China Sits at the Heart of Insilico’s Vision for an AI Driven Drug Discovery Revolution

Why China Sits at the Heart of Insilico’s Vision for an AI Driven Drug Discovery Revolution

  • December 31, 2025

A Bold Vision for the Future of Medicine Biotechnology company Insilico Medicine is pursuing an ambitious goal that blends artificial intelligence with the uncertainties of drug discovery. Backed by the Hong Kong Investment Corporation, the firm is working to build what its founder